ELAN vs PAHC
ELAN: Elanco is a global animal health company providing pharmaceuticals, vaccines, and nutrition solutions for livestock, poultry, and companion animals. PAHC: Phibro manufactures and distributes nutritional additives, pharmaceutical products, and specialty ingredients for animal health and nutritional enhancement worldwide.
Side-by-side fundamentals
| Metric | ELAN | PAHC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $25.34 | $33.81 | |
| Market cap as of 2026-07-23 | $12.7B | $1.4B | |
| P/E as of 2026-07-23 | n/a | 14.42 | |
| PEG as of 2026-07-23 | n/a | 0.62 | |
| Net margin as of 2026-07-23 | -5.0% | +6.3% | PAHC higher |
| Gross margin as of 2026-07-23 | +55.1% | +32.8% | ELAN higher |
| Operating margin as of 2026-07-23 | -3.7% | +12.0% | PAHC higher |
| ROE as of 2026-07-23 | -3.6% | +29.5% | PAHC higher |
| ROA as of 2026-07-23 | -1.8% | +6.8% | PAHC higher |
| Debt / equity as of 2026-07-23 | 0.61 | 2.03 | ELAN lower |
| Revenue growth (YoY) as of 2026-07-23 | +10.5% | +26.0% | PAHC higher |
| Revenue CAGR (3y) SEC XBRL | +2.2% | +11.2% | PAHC higher |
| Dividend yield as of 2026-07-23 | n/a | +1.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 1.72 | 0.48 | |
| 1-year return as of 2026-07-22 close | +73.6% | +15.7% | ELAN higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.